{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:21:01Z","timestamp":1789543261369,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.psyneuen.2016.11.035","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T01:17:29Z","timestamp":1480900649000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression"],"prefix":"10.1016","volume":"77","author":[{"given":"Christina M.","family":"Hough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa S.","family":"Epel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly St.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor I.","family":"Reus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Saverio","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen M.","family":"Wolkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Synthia H.","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2016.11.035_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.psychres.2004.05.016","article-title":"Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings","volume":"128","author":"Assies","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF03346666","article-title":"Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans","volume":"33","author":"Berardelli","year":"2010","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0015","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0006-3223(99)00066-9","article-title":"Dehydroepiandrosterone treatment of midlife dysthymia","volume":"45","author":"Bloch","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0020","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1073\/pnas.95.8.4678","article-title":"Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development","volume":"95","author":"Compagnone","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000079980","article-title":"Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine","volume":"50","author":"Deuschle","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0006-3223(01)01198-2","article-title":"Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults","volume":"50","author":"Fabian","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0035","doi-asserted-by":"crossref","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0040","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"First","year":"1997"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0045","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.8001tx3c.e07","article-title":"Remission as the gold standard of treatment for depression with and without physical symptoms","volume":"70","author":"Fishbain","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/npp.2008.46","article-title":"DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system","volume":"34","author":"Genud","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0060","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.psyneuen.2006.03.008","article-title":"Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression","volume":"31","author":"Hsiao","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-0447.2001.t01-1-00003.x","article-title":"Major depressive disorder: longitudinal symptomatic structure, relapse and recovery","volume":"104","author":"Judd","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-0327(03)00054-5","article-title":"Residual symptoms at remission from depression: impact on long-term outcome","volume":"80","author":"Kennedy","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912709922007903","article-title":"DHEA and DHEA-S: a review","volume":"39","author":"Kroboth","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2012.09.004","article-title":"Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls","volume":"146","author":"Kurita","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0085","doi-asserted-by":"crossref","first-page":"e1001051","DOI":"10.1371\/journal.pbio.1001051","article-title":"Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis","volume":"9","author":"Lazaridis","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1600-0447.106.s415.2.x","article-title":"How do you define remission?","author":"Lecrubier","year":"2002","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yfrne.2008.11.002","article-title":"Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)","volume":"30","author":"Maninger","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.psyneuen.2008.08.004","article-title":"The ratio of cortisol\/DHEA in treatment resistant depression","volume":"34","author":"Markopoulou","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF03343629","article-title":"Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels","volume":"22","author":"Mazza","year":"1999","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2007.04.011","article-title":"Neurosteroid regulation of central nervous system development","volume":"116","author":"Mellon","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-3223(00)00955-0","article-title":"Altered salivary dehydroepiandrosterone levels in major depression in adults","volume":"48","author":"Michael","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psyneuen.2015.05.006","article-title":"DHEAS and cortisol\/DHEAS-ratio in recurrent depression: state, or trait predicting 10-year recurrence?","volume":"59","author":"Mocking","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00737-009-0106-1","article-title":"Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women","volume":"13","author":"Morgan","year":"2010","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hup.2400","article-title":"Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants","volume":"29","author":"Morita","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.pnpbp.2007.12.001","article-title":"Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders","volume":"32","author":"P\u00e9rez-Neri","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpsychires.2009.11.015","article-title":"Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment","volume":"44","author":"Paslakis","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000029018","article-title":"Remission and residual symptomatology in major depression","volume":"31","author":"Paykel","year":"1998","journal-title":"Psychopathology"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/1389450115666140717111116","article-title":"The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review","volume":"15","author":"Peixoto","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0155","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.neuroscience.2008.10.035","article-title":"Synergistic effects of dehydroepiandrosterone and fluoxetine on proliferation of progenitor cells in the dentate gyrus of the adult male rat","volume":"158","author":"Pinnock","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0160","series-title":"Outpatient Management of Depression","author":"Preskorn","year":"2009"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.163.1.59","article-title":"Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV\/AIDS","volume":"163","author":"Rabkin","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0170","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1097\/00001756-199809140-00028","article-title":"Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test","volume":"9","author":"Reddy","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0175","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0180","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0185","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jpsychires.2008.07.003","article-title":"Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients","volume":"43","author":"Sch\u00fcle","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archpsyc.62.2.154","article-title":"Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression","volume":"62","author":"Schmidt","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0195","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s007020050077","article-title":"Plasma dehydroepiandrosterone sulfate in unipolar major depression: short communication","volume":"105","author":"Takebayashi","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.156.4.646","article-title":"Double-blind treatment of major depression with dehydroepiandrosterone","volume":"156","author":"Wolkowitz","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/15622970109026799","article-title":"Stress hormone-related psychopathology: pathophysiological and treatment implications","volume":"2","author":"Wolkowitz","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.035_bib0220","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.psychres.2015.05.093","article-title":"Serum DHEAS levels are associated with the development of depression","volume":"229","author":"Zhu","year":"2015","journal-title":"Psychiatry Res."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016307466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016307466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:55:24Z","timestamp":1759683324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016307466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":44,"alternative-id":["S0306453016307466"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.11.035","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}